LinkMed

The LinkMed portfolio consists of a number of life science companies, several of which are nearing the commercialization phase, while others are already selling their products or services. Between them, these companies account for more than 50 different projects in a wide range of therapeutic areas – from HIV and cancer to eye disease and allergies.

COMPANIES IN SEVERAL SECTORS
LinkMed has created a portfolio of twelve companies, four in drug development and biotechnology and eight in diagnostics and medical technology

MANY COMPANIES, LOWER RISKS
By investing in several companies, we spread risks and reduce our exposure to the development in individual projects. Our goal is to continually develop and manage between 15 and 20 portfolio companies. Therefore, we plan to invest in several new companies in the coming years.

Biomedical sensors – measurement tools

Operations: BioResonator develops biomedical sensors and diagnostics for several healthcare sectors. The company focuses primarily on the development of new technology and instruments for measuring eye pressure. Pilot studies have also been conducted in cancer diagnostics and oedema diagnostics.

Sektor: Diagnostics and medical technology

Therapeutic area: Eye disease/cancer

CEO: Mikael Lindblad

Chairman: Ingemar Lagerlöf

Venture manager: Agneta Edberg

Ownership stake: 49.2%

Address: BioResonator AB
Box 7952
SE-907 19 Umeå
Sweden

www.bioresonator.se

Back